Search Within

Adam Jacob Schoenfeld

Formats
  1. Meeting Abstract (67)
  2. Journal Article (58)
  3. Review (5)
  4. Correspondence (3)
  5. Editorial (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (138)
  2. Hematologic Malignancies, Division of (138)
  3. Hematology-Oncology Fellows (138)
  4. Solid Tumor Oncology Division (138)
  5. Thoracic Oncology (138)
  6. Weinberg Fellows (138)

More Groups

People
  1. Gregory Riely (38)
  2. Marc Ladanyi (36)
  3. Arielle Elkrief (28)
  4. Charles Rudin (27)
  5. Hira Rizvi (27)
  6. Matthew Hellmann (25)

More People

Years
  1. 2025 (18)
  2. 2024 (33)
  3. 2023 (24)
  4. 2022 (17)
  5. 2021 (18)
  6. 2020 (17)

More Years

Publications
  1. Journal of Thoracic Oncology (33)
  2. Journal of Clinical Oncology (28)
  3. Clinical Cancer Research (13)
  4. Annals of Oncology (9)
  5. Journal for ImmunoTherapy of Cancer (9)
  6. Cancer Research (5)

More Publications

Publishers
  1. Elsevier Inc. (40)
  2. American Society of Clinical Oncology (30)
  3. American Association for Cancer Research (22)
  4. Oxford University Press (10)
  5. Biomed Central Ltd (9)
  6. Nature Publishing Group (7)

More Publishers

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of AFNT-211, autologous CD4(+) and CD8(+) T cells engineered to express a high avidity HLA-A(*)11:01-restricted, KRAS G12V-specific transgenic TCR; CD8α/β coreceptor; and FAS-41BB switch receptor in patients with advanced or metastatic solid tumors
    Meeting Abstract

    Basu, S. K.; Khan, B.; Payumo, F.; Wan, R.; Chiorean, E. G.; Gahvari, Z.; Hecht, J. R.; Hurwitz, M. E.; Leidner, R. S.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Entering a new era of tumor-infiltrating lymphocyte cell therapy innovation
    Review

    Amaria, R. N.; Komanduri, K. V.; Schoenfeld, A. J.; Ramsingh, G.; Burga, R. A.; Jagasia, M. H.
    Cytotherapy (2025)

    Fulltext@MSK | Save
  • Patient-reported experience with an immunotherapy telehealth platform
    Meeting Abstract

    Daly, R. M.; Malling, C.; Dagostino, A.; Bange, E. M.; Preeshagul, I. R.; Aggen, D. H.; Carlo, M.; Chen, M. F.; Eng, J.; Ng, K. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Use of a large language model (LLM) for pan-cancer automated detection of anti-cancer therapy toxicities and translational toxicity research
    Meeting Abstract

    Bakouny, Z.; Ahmed, N.; Fong, C.; Rahman, A.; Perea-Chamblee, T.; Pichotta, K.; Waters, M.; Fu, C.; Jeng, M. Y.; Lee, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Gene copy deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic features and association with the outcomes of immunotherapy with or without chemotherapy in nonsquamous NSCLC
    Journal Article

    Gandhi, M. M.; Elkrief, A.; Moore, C. G.; Ricciuti, B.; Alessi, J. V.; Richards, A. L.; Tischfield, S.; Williams, J.; Lamberti, G.; Pecci, F.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Factors associated with disease progression after discontinuation of immune checkpoint inhibitors for immune-related toxicity in patients with advanced non-small cell lung cancer
    Journal Article

    Pecci, F.; Thummalapalli, R.; Alden, S. L.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Jeng, M.; Egger, J. V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Tumor immunophenotypic correlates in patients aged 80 years or older with non-small cell lung cancer and outcomes to first-line pembrolizumab in PD-L1 high (≥50%) patients
    Journal Article

    Barrichello, A. P. C.; Elkrief, A.; Ricciuti, B.; Ganta, T.; Marron, T. U.; Wang, X.; Lotter, W.; Lindsay, J.; Santo, V.; Cortellini, A.; more...
    Clinical Lung Cancer (2025)

    Fulltext@MSK | Save
  • Safety and tolerability of lete-cel in NSCLC—Reply
    Correspondence

    Altan, M.; Lopes, G.; Hiltermann, T. J. N.; Govindan, R.; Villaruz, L. C.; Calvo, E.; Edelman, M. J.; Furqan, M.; Neal, J.; Felip, E.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Can longitudinal biomarkers guide treatment decisions? Time will tell
    Editorial

    Jeng, M. Y.; Schoenfeld, A. J.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A clinical benchmark of public self-supervised pathology foundation models
    Journal Article

    Campanella, G.; Chen, S.; Singh, M.; Verma, R.; Muehlstedt, S.; Zeng, J.; Stock, A.; Croken, M.; Veremis, B.; Elmas, A.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save